Cargando…
Effects on Gastroesophageal Reflux of Donkey Milk-Derived Human Milk Fortifier Versus Standard Fortifier in Preterm Newborns: Additional Data from the FortiLat Study
Background: Feeding intolerance is a frequent diagnosis in very preterm infants. As seen in the FortiLat trial, human milk fortification with the new donkey milk-derived human milk fortifier (DF) seems to improve feeding tolerance in these infants. The aim of this study was to evaluate the effects o...
Autores principales: | Cresi, Francesco, Maggiora, Elena, Pirra, Alice, Tonetto, Paola, Rubino, Carlotta, Cavallarin, Laura, Giribaldi, Marzia, Moro, Guido E., Peila, Chiara, Coscia, Alessandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400944/ https://www.ncbi.nlm.nih.gov/pubmed/32708446 http://dx.doi.org/10.3390/nu12072142 |
Ejemplares similares
-
A Novel Donkey Milk–derived Human Milk Fortifier in Feeding Preterm Infants: A Randomized Controlled Trial
por: Bertino, Enrico, et al.
Publicado: (2019) -
Urinary Metabolomic Profile of Preterm Infants Receiving Human Milk with Either Bovine or Donkey Milk-Based Fortifiers
por: Giribaldi, Marzia, et al.
Publicado: (2020) -
Nutritional adequacy of a novel human milk fortifier from donkey milk in feeding preterm infants: study protocol of a randomized controlled clinical trial
por: Coscia, Alessandra, et al.
Publicado: (2018) -
The “Fortilat” Randomized Clinical Trial Follow-Up: Neurodevelopmental Outcome at 18 Months of Age
por: Peila, Chiara, et al.
Publicado: (2020) -
The “Fortilat” Randomized Clinical Trial Follow-Up: Auxological Outcome at 18 Months of Age
por: Peila, Chiara, et al.
Publicado: (2020)